Replies to post #4878 on FDA Plays

[kei]

ONTY - brand new future for onty (^^)/

onty has many pipelines ....imo
http://www.oncothyreon.com/pipeline/overview.html

ress Release Source: Oncothyreon Inc. On Thursday June 17, 2010, 8:00 am EDT

SEATTLE, WA, June 17 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:ONTY - News) today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., are resuming the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine) in non-small cell lung cancer (NSCLC), including the Phase 3 START and INSPIRE trials. The treatment and enrollment in these studies will restart after approval by the local regulatory authorities and ethics committees. The announcement follows a decision by the U.S. Food and Drug Administration (FDA) to partially lift the clinical hold it placed on the Investigational New Drug (IND) application for BLP25 liposome vaccine in March 2010 and allow the START trial to be resumed.